Search alternatives:
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a fold » _ fold (Expand Search), 5 fold (Expand Search), 2 fold (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a fold » _ fold (Expand Search), 5 fold (Expand Search), 2 fold (Expand Search)
-
561
-
562
-
563
-
564
-
565
DNA methylation of RALBP1 is associated with a decrease in gene expression.
Published 2013“…<p>A CpG site in the promoter region of <i>RALBP1</i> showed A) increased DNA methylation in response to exercise as well as B) a decrease in mRNA expression. …”
-
566
-
567
-
568
-
569
-
570
-
571
Retigabine and ML213 decrease the constriction tone of human detrusor strips.
Published 2015“…<p>(A) The original DSM tension recordings illustrate the relaxatory effect of retigabine and ML213, which are K<sub>v</sub>7.2–7.5 and K<sub>v</sub>7.2/7.4/7.5 channel activators, respectively. …”
-
572
-
573
-
574
-
575
-
576
-
577
-
578
VRK1 overexpression is seen in human breast cancer and is associated with decreased relapse-free survival.
Published 2018“…Data for cancer subtypes are shown in boxes numbered 1–11: 1: benign breast neoplasm (rank 6459, 1.4 fold-change, NS), 2: breast carcinoma (rank 833, 1.5 fold-change, p = 3.83x10<sup>-5</sup>), 3: breast phyllodes tumor (rank 512, 1.2 fold-change, p = 0.002), 4: ductal breast carcinoma in situ (rank 1969, 1.5 fold-change, p = 0.002), 5: invasive breast carcinoma (rank 1060, 1.6 fold-change, p = 1.28x10<sup>-5</sup>), 6: invasive ductal and invasive lobular breast carcinoma (rank 941, 1.5 fold-change, p = 6.76x10<sup>-22</sup>), 7: invasive ductal breast carcinoma (rank 613, 1.5-fold change, p = 2.71x10<sup>-71</sup>), 8: invasive lobular breast carcinoma (rank 947, 1.3 fold-change, p = 3.64x10<sup>-28</sup>), 9: medullary breast carcinoma (rank 400, 1.8 fold-change, p = 3.25x10<sup>-12</sup>), 10: mucinous breast carcinoma (rank 1932, 1.4 fold-change, p = 7.41x10<sup>-10</sup>) and 11: tubular breast carcinoma (rank 1253, 1.4 fold-change, p = 1.24x10<sup>-17</sup>). …”
-
579
-
580